65 /100
HIGH RISK
Score updated Jul 14, 2026

RGBP — Regen BioPharma, Inc. Dilution Risk Tracker

Track RGBP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track RGBP — Get alerts when the score changes →

As of July 14, 2026, Regen BioPharma, Inc. (RGBP) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. Regen BioPharma, Inc. has a market capitalization of $153.6K, 511.96M shares outstanding.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
95
📊 Float Risk
14
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
33%
🔁 Convertible Conversion 60%
• Major convertible overhang: 2701% potential dilution
• Convertible risk score very high (85/100)
📉 Score Deterioration 10%
• Score in HIGH risk zone (65/100)
🔔 Track RGBP — Get forecast alerts →

💹 Market Data

Market Cap$153.6K
Shares Outstanding511.96M
Float461.18M
Cash$271
Debt$107.1K
Short InterestN/A

🏛 Institutional Holdings

Institutional data not yet available.

📉 Short Interest

Short Interest210.0K
Days to Cover1.0
% of Float0.1%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Sep 30, 2024
xbrl XBRL CONVERTIBLE Jun 30, 2020
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for RGBP Shareholders

Regen BioPharma, Inc. (RGBP) has a DilutionScore of 65/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

Cash runway is a key watch item: RGBP has approximately 0 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for RGBP in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for RGBP alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track RGBP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RGBP — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for RGBP
📊 RGBP FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 RGBP Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.